These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3622502)

  • 1. In vitro activity of four new quinolones in Mueller-Hinton broth and peritoneal dialysis fluid.
    Weissauer-Condon C; Engels I; Daschner FD
    Eur J Clin Microbiol; 1987 Jun; 6(3):324-6. PubMed ID: 3622502
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens.
    Gesu GP; Eftimiadi C; Debbia E; Schito GC
    Drugs Exp Clin Res; 1987; 13(2):79-84. PubMed ID: 3556122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The post-antimicrobial suppressive effect of quinolone agents.
    Neu HC; Kumada T; Chin NX; Mandell W
    Drugs Exp Clin Res; 1987; 13(2):63-7. PubMed ID: 3107958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity and resistance of 4-quinolones].
    Bauernfeind A
    Infection; 1986; 14 Suppl 3():S186-7. PubMed ID: 3531027
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro effect of rosoxacin on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Le Van Thoi J; Chanal M; Cluzel M; Fleurette J; Forey F; Thabaut A; Meyran M; Vandekerkove M; Sicard D; Acar JF; Kitzis MD; Veron M; Fauchere JL
    Pathol Biol (Paris); 1983 Jun; 31(6):504-8. PubMed ID: 6348657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.
    Xicota MA; Coll R; Esteve M; Moros M; Parés J
    Drugs Exp Clin Res; 1987; 13(3):133-6. PubMed ID: 3622242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.
    Kussmann M; Schuster L; Zeitlinger M; Pichler P; Reznicek G; Wiesholzer M; Burgmann H; Poeppl W
    Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2257-63. PubMed ID: 26337433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method.
    Koeth LM; King A; Knight H; May J; Miller LA; Phillips I; Poupard JA
    J Antimicrob Chemother; 2000 Sep; 46(3):369-76. PubMed ID: 10980162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues.
    Dette GA; Knothe H; Schönenbach B; Plage G
    J Antimicrob Chemother; 1983 Jun; 11(6):517-24. PubMed ID: 6885678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gyrase inhibitor].
    Forth W
    Klin Wochenschr; 1985 Oct; 63(19):1036-9. PubMed ID: 2999503
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions between antibacterial agents of the quinolone group and nitrofurantoin.
    Shah S; Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21(1):41-8. PubMed ID: 3356622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic tolerance of peritoneal bacterial isolates in dialysis fluids.
    Zelenitsky S; Franczuk C; Fine A; Ariano R; Harding G
    J Antimicrob Chemother; 2002 May; 49(5):863-6. PubMed ID: 12003985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Broad-spectrum quinolones (2d-generation quinolones)].
    Neuman M
    Therapie; 1986; 41(2):123-8. PubMed ID: 3726784
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro activity of pefloxacin compared with six other quinolones.
    Ligtvoet EE; Wickerhoff-Minoggio T
    J Antimicrob Chemother; 1985 Oct; 16(4):485-90. PubMed ID: 3864776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patients.
    Bowker KE; Wootton M; Holt HA; MacGowan AP
    J Antimicrob Chemother; 2002 Mar; 49(3):578-80. PubMed ID: 11864965
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline.
    Tan TY; Ng LS; Chen DM
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):93-5. PubMed ID: 20727479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action, and in vitro and in vivo activities of the fluoroquinolones.
    Fernandes PB
    J Clin Pharmacol; 1988 Feb; 28(2):156-68. PubMed ID: 3283179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.